跳至主要内容
临床试验/NCT03110627
NCT03110627Unknown不适用

Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead: The Dx-AF Study

Unity Health Toronto9 个研究点 分布在 1 个国家目标入组 188 人开始时间: 2017年3月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
188
试验地点
9
主要终点
Atrial Fibrillation or atrial flutter lasting at least 6 minutes

研究概览

简要总结

This study aims to compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.

详细描述

Recipients of implantable defibrillators (ICD) are at high risk of developing both AF and stroke, given the presence of multiple cardiovascular risk factors. Oral anticoagulation can prevent most strokes in patients with AF; provided that AF is recognized before a stroke occurs. Up to about 40% of incident AF may be sub-clinical, producing minimal or no symptoms, or being too short to allow detection.

DX AF is a prospective, randomized-controlled, open-label trial. Patients who are identified on clinical grounds for a single-chamber ICD will be randomized to a VDD ICD (experimental group) or single chamber ICD (control group).

The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
51 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with ischemic or non-ischemic cardiomyopathy,
  • •LVEF<50%, scheduled for primary or secondary prevention ICD
  • •Treating physicians feel that the use of single chamber ICD is appropriate
  • •No ECG-documented history of AF or flutter
  • •Age > 50 years

排除标准

  • •Known AF or flutter
  • •Current use of class I or III anti-arrhythmic medications
  • •Participants unwilling to attend study follow-up visits, considered unreliable for compliance or with an anticipated life expectancy less than 3 years

研究组 & 干预措施

VDD ICD

Experimental

VDD ICD - A single-lead ICD system with the ability to sense atrial rhythm from the floating electrode (a VDD-ICD known as the DX) - Experimental group

干预措施: VDD ICD (experimental group) (Device)

VVI ICD

Active Comparator

VVI ICD - Single chamber ICD system - Control group

干预措施: Single chamber VVI ICD (control group) (Device)

结局指标

主要结局

Atrial Fibrillation or atrial flutter lasting at least 6 minutes

时间窗: During the entire time of follow up - 3 years

Atrial Fibrillation or atrial flutter lasting at least 6 minutes detected by the ICD, ECG, Holter monitor or telemetry.

次要结局

  • New pericardial effusion(60 days)
  • Cardiac tamponade(60 days)
  • Need for any ICD lead repositioning or replacement(60 days)
  • Pneumothorax(60 days)
  • Procedure-related death or wound infection(60 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验